EQUITY (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended				9 Months Ended
	Jul. 26, 2022	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Jul. 31, 2024	Oct. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized						1,000,000,000	1,000,000,000
Common stock, par value						$ 0.001	$ 0.001
Reverse stock split	1 for 26
Proceeds from sale of common stock				$ 23,525	$ 50,593
Discount on common stock					$ 75,889	$ (75,889)	$ (75,889)
Shares price			$ 0.5701
Stock based compensation			$ 96,917
Common stock, shares issued						19,090,078	19,090,078
Common stock, shares outstanding						19,090,078	19,090,078
Preferred stock, shares authorized						2,500,000	2,500,000
Preferred stock, par value						$ 0.001	$ 0.001
Conversion of stock, description						one thousand (1,000) fully paid and nonassessable shares of Common Stock (the “Series A-1 Conversion Ratio”).
Value of shares issued to CEO		$ 2,516,727
Preferred stock, shares issued						1,584,254	834,254
Preferred stock, shares outstanding						1,584,254	834,254
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized						5,000,000	5,000,000
Preferred stock, par value						$ 0.001	$ 0.001
Shares issued to CEO		750,000
Preferred stock, shares issued						1,584,254	837,899
Preferred stock, shares outstanding						1,584,254	837,899
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Private placement of common shares, shares				391,412	4,864,668
Stock based compensation for services, shares			170,000